EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Pseudo-Richter transformation in a patient with chronic lymphocytic leukemia after cessation of fixed duration venetoclax/ibrutinib treatment

Raphael Battegay, Dominik Heim, Stefan Dirnhofer

Annals of Hematology · 20.05.2026 · 105 (8)

DOI: 10.1007/s00277-026-07069-y ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of Hematology, online erschienen am 20.05.2026. Verfasst von Raphael Battegay und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of hematology, University Hospital Basel, Basel, Switzerland. Raphael.battegay@usb.ch. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, Bridged Bicyclo Compounds, Heterocyclic, Adenine, Sulfonamides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Lymphocytic, Chronic, B-CellBridged Bicyclo Compounds, HeterocyclicAdenineSulfonamidesAntineoplastic Combined Chemotherapy ProtocolsHumansMaleAgedPiperidinesPyrazolesPyrimidinesTreatment Interruption

Stichwörter der Autor:innen

Bruton Tyrosine kinase inhibitorChronic lymphatic leukemiaIbrutinibPseudo-Richter transformationVenetoclax

Substanzen

PiperidinesibrutinibBridged Bicyclo Compounds, HeterocyclicAdeninevenetoclaxSulfonamidesPyrazolesPyrimidines

Autor:innen und Institutionen

  • Department of hematology, University Hospital Basel, Basel, Switzerland. Raphael.battegay@usb.ch.
  • Department of hematology, Basel University Hospital, Petersgraben 4, Basel, 4031, Switzerland. Raphael.battegay@usb.ch.
  • Department of hematology, University Hospital Basel, Basel, Switzerland.
  • Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.

Zitieren

APA

Battegay, R., Heim, D., & Dirnhofer, S. (2026). Pseudo-Richter transformation in a patient with chronic lymphocytic leukemia after cessation of fixed duration venetoclax/ibrutinib treatment. Annals of Hematology, 105(8). https://doi.org/10.1007/s00277-026-07069-y

Vancouver

Battegay R, Heim D, Dirnhofer S. Pseudo-Richter transformation in a patient with chronic lymphocytic leukemia after cessation of fixed duration venetoclax/ibrutinib treatment. Annals of Hematology. 2026;105(8). doi:10.1007/s00277-026-07069-y

BibTeX
@article{Battegay2026,
  author = {Battegay, Raphael and Heim, Dominik and Dirnhofer, Stefan},
  title = {Pseudo-Richter transformation in a patient with chronic lymphocytic leukemia after cessation of fixed duration venetoclax/ibrutinib treatment},
  journal = {Annals of Hematology},
  year = {2026},
  volume = {105},
  number = {8},
  doi = {10.1007/s00277-026-07069-y}
}
Kostenlos starten →